The use of topical therapies to treat onychomycosis.

[1]  E. Mahgoub.  Clinical trial with clotrimazole cream (Bay b 5097) in dermatophytosis and onychomycosis , 1975, Mycopathologia.

[2]  M. Lecha.  Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trial in Spain , 2001, The British journal of dermatology.

[3]  A. Gupta.  Ciclopirox nail lacquer: a brush with onychomycosis. , 2001, Cutis.

[4]  H. Ulbricht,et al.  A multicenter, open-label study of the efficacy and safety of ciclopirox nail lacquer solution 8% for the treatment of onychomycosis in patients with diabetes. , 2001, Cutis.

[5]  B. Elewski,et al.  The safety and efficacy of terbinafine in patients with diabetes and patients who are HIV positive. , 2001, Cutis.

[6]  M. Bohn,et al.  The dermatopharmacologic profile of ciclopirox 8% nail lacquer. , 2000, Journal of the American Podiatric Medical Association.

[7]  M. Bohn,et al.  Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis. , 2000, Journal of the American Academy of Dermatology.

[8]  A. Rachlis,et al.  Epidemiology and prevalence of onychomycosis in HIV‐positive individuals , 2000, International journal of dermatology.

[9]  Aditya K. Gupta,et al.  Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis. , 2000, Journal of the American Academy of Dermatology.

[10]  Aditya K. Gupta,et al.  Ciclopirox nail lacquer solution 8% in the 21st century. , 2000, Journal of the American Academy of Dermatology.

[11]  J. Czernielewski,et al.  A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region , 2000, The British journal of dermatology.

[12]  Aditya K. Gupta.  Onychomycosis in the Elderly , 2000, Drugs & aging.

[13]  B. Piraccini,et al.  Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases. , 2000, Journal of the American Academy of Dermatology.

[14]  A. Gupta.  Ciclopirox nail lacquer topical solution 8%. , 2000, Skin therapy letter.

[15]  Evans,et al.  Treatment of superficial white onychomycosis with topical terbinafine cream , 1999, The British journal of dermatology.

[16]  T. Syed,et al.  Treatment of toenail onychomycosis with 2% butenafine and 5% Melaleuca alternifolia (tea tree) oil in cream , 1999, Tropical medicine & international health : TM & IH.

[17]  Archer,et al.  Scytalidium hyalinum onychomycosis successfully treated with 5% amorolfine nail lacquer , 1999, The British journal of dermatology.

[18]  R. Summerbell,et al.  Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey , 1998, The British journal of dermatology.

[19]  E. Haneke,et al.  Itraconazole in the Treatment of Onychomycosis: A Double-Blind Comparison with Miconazole , 1998, Dermatology.

[20]  R. Bergman,et al.  Treatment of onychomycosis: a randomized, double‐blind comparison study with topical bifonazole‐urea ointment alone and in combination with short‐duration oral griseofulvin , 1997, International journal of dermatology.

[21]  A. Bonifaz,et al.  EFFICACY AND SAFETY OF BIFONAZOLE UREA IN THE TWO‐PHASE TREATMENT OF ONYCHOMYCOSIS , 1995, International journal of dermatology.

[22]  A. Polak‐Wyss.  Mechanism of action of antifungals and combination therapy , 1995 .

[23]  J. Marty.  Amorolfine nail lacquer: a novel formulation , 1995 .

[24]  H. Bryson,et al.  Amorolfine. A review of its pharmacological properties and therapeutic potential in the treatment of onychomycosis and other superficial fungal infections. , 1995, Drugs.

[25]  Scher Rk,et al.  A double-blind, vehicle-controlled study of the safety and efficacy of Fungoid Tincture in patients with distal subungual onychomycosis of the toes. , 1994 .

[26]  Buck Ds,et al.  Comparison of two topical preparations for the treatment of onychomycosis: Melaleuca alternifolia (tea tree) oil and clotrimazole. , 1994 .

[27]  K. Wörz,et al.  [Therapy with ciclopirox lacquer of onychomycoses caused by molds]. , 1994, Mycoses.

[28]  H. Ulbricht,et al.  THERAPIE VON SCHIMMELPILZ-ONYCHOMYKOSEN MIT CICLOPIROX-LACK , 1994 .

[29]  J. Cohen,et al.  Open-label study of the safety and efficacy of naftifine hydrochloride 1 percent gel in patients with distal subungual onychomycosis of the fingers. , 1993, Cutis.

[30]  A. Polak.  Kinetics of amorolfine in human nails , 1993, Mycoses.

[31]  J. Lauharanta.  Comparative efficacy and safety of amorolfine nail lacquer 2% versus 5% once weekly , 1992, Clinical and experimental dermatology.

[32]  G. Klecak,et al.  Loceryl® nail lacquer—realization of a new galenical approach to onychomycosis therapy , 1992, Clinical and experimental dermatology.

[33]  C. Clarke,et al.  Comparative efficacy and safety of amorolfine nail lacquer 5% in onychomycosis, once‐weekly versus twice‐weekly , 1992, Clinical and experimental dermatology.

[34]  A. Polak.  Preclinical data and mode of action of amorolfine , 1992, Dermatology.

[35]  H. Mensing,et al.  Determination of the subungual antifungal activity of amorolfine after 1 month's treatment in patients with onychomycosis: comparison of two nail lacquer formulations , 1992, Clinical and experimental dermatology.

[36]  J. Cohen,et al.  Open-label study of the safety and efficacy of Fungoid tincture in patients with distal subungual onychomycosis of the toes. , 1992, Cutis.

[37]  D. Reinel.  Topical treatment of onychomycosis with amorolfine 5% nail lacquer: comparative efficacy and tolerability of once and twice weekly use. , 1992, Dermatology.

[38]  T. Franz.  Absorption of amorolfine through human nail. , 1992, Dermatology.

[39]  H. Yan,et al.  A clinical and laboratory study of ciclopirox olamine (8% Batrafen) in the treatment of onychomycosis. , 1991, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.

[40]  R. Arenas,et al.  Onychomycosis Treated with Itraconazole or Griseofulvin Alone with and without a Topical Antimycotic or Keratolytic Agent , 1991, International journal of dermatology.

[41]  Y. Lü,et al.  Efficacy of ciclopiroxolamine 1% cream in onychomycosis and tinea pedis , 1991, Mycoses.

[42]  M. S. Valinsky,et al.  Treatment of onychomycosis with nail avulsion and topical ketoconazole. , 1991, Journal of the American Podiatric Medical Association.

[43]  C. De Simone,et al.  The treatment of onychomycosis with a new form of tioconazole. , 1988, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy.

[44]  R. Hay,et al.  The topical treatment of onychomycosis using a new combined urea/imidazole preparation , 1988, Clinical and experimental dermatology.

[45]  R. Hay,et al.  A comparison of tioconazole 28% nail solution versus base as an adjunct to oral griseofulvin in patients with onychomycosis , 1987, Clinical and experimental dermatology.

[46]  Y. Clayton,et al.  Tioconazole nail solution—an open study of its efficacy in onychomycosis , 1985, Clinical and experimental dermatology.

[47]  S. Goldsmith.  Vitamin E and onychomycosis. , 1983, Journal of the American Academy of Dermatology.

[48]  B. Bentley‐Phillips.  The treatment of onychomycosis with miconazole tincture. , 1982, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[49]  O. Rollman.  Treatment of onychomycosis by partial nail avulsion and topical miconazole. , 1982, Dermatologica.

[50]  T. Höhler,et al.  [On the local efficacy of ciclopiroxolamine in onychomycoses (author's transl)]. , 1981, Arzneimittel-Forschung.

[51]  A. Botter.  Topical treatment of nail and skin infections with miconazole, a new broad‐spectrum antimycotic , 1971, Mykosen.